Publikationen

Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: a phase III, multicentre, randomised trial (SUMIT)

Carvajal R, Piperno-Neumann S, Kapiteijn E, Chapman P, Frank S, Joshua A, Piulats J, Wolter P, Cocquyt V, Chmielowski B, Evans TR, Gastaud L, Linette G, Berking C, Schachter J, Rodrigues M, Shoushtari A, Clemett D, Ghiorghiu D, Mariani G, Spratt S, Lovick S, Barker P, Kilgour E, Lai Z, Schwartz G, Nathan P (2018)  J Clin Oncol, accepted (IF 24)

Birt-Hogg-Dubé-Syndrom: ein zu selten diagnostiziertes erbliches Tumorsyndrom

Steinlein OS, Ertl-Wagner B, Ruzicka T, Sattler EC (2018) JDDG im Druck

Genomewide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2.

Fischer J, Degenhardt F, Hofmann A, Redler S, Basmanav FB, Heilmann-Heimbach S, Hanneken S, Giehl KA, Wolff H, Moebus S, Kruse R, Lutz G, Blaumeiser B, Böhm M, Garcia Bartels N, Blume-Peytavi U, Petukhova L, Christiano AM, Nöthen MM, Betz RC (2017) Exp Dermatol 26(6):536-541

Chanarin-Dorfman syndrome with rare renal involvement.

Verma SB, Mittal A, Wollina U, Eckstein GH, Gohel K, Giehl K (2017) Br J Dermatol 176(2):545-548.

Diminished protein-bound ?-hydroxylated ceramides in the skin of patients with ichthyosis with 12R-lipoxygenase (LOX) or eLOX-3 deficiency.

Dick A, Tantcheva-Poór I, Oji V, Giehl KA, Fischer J, Krieg P, Schneider H, Rauh M (2017) Br J Dermatol 177(4):e119-e121.

S1 guidelines for the diagnosis and treatment of ichthyoses - update

Oji V, Preil ML, Kleinow B, Wehr G, Fischer J, Hennies HC, Hausser I, Breitkreutz D, Aufenvenne K, Stieler K, Tantcheva-Poór I, Weidinger S, Emmert S, Hamm H, Perusquia-Ortiz AM, Zaraeva I, Diem A, Giehl K, Fölster-Holst R, Kiekbusch K, Höger P, Ott H, Traupe H (2017)J Dtsch Dermatol Ges 15(10):1053-1065

Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review.

Heppt MV, Steeb T, Schlager JG, Rosumeck S, Dressler C, Ruzicka T, Nast A, Berking C (2017) Cancer Treat Rev 60:44-52 (IF 8,6)

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.

Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C (2017) Eur J Cancer 82:56-65 (IF 6,0)

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.

Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, Göppner D, Schlaak M, Pföhler C, Utikal J, Heinzerling L, Cosgarea I, Engel J, Eckel R, Martens A, Mirlach L, Satzger I, Schubert-Fritschle G, Tietze JK, Berking C (2017) Eur J Cancer 81:36-44 (IF 6,0)

Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients.

Heppt MV, Schlaak M, Eigentler TK, Kähler KC, Kiecker F, Loquai C, Meier F, Tomsitz D, Brenner N, Niesert AC, Thonke R, Hauschild A, Berking C (2017) Ann Oncol. 2017 Sep 18. doi: 10.1093/annonc/mdx538 (IF 11,9)

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe.

Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pföhler C, Kellner I, Meier F, Kähler K, Mohr P, Berking C, Haas G, Helwig C, Oksen D, Schadendorf D, Mahnke L, Bharmal M (2017) Oncotarget 8:79731-79741 (IF 5,2)

Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein.

Laviolette LA, Mermoud J, Calvo IA, Olson N, Boukhali M, Steinlein OK, Roider E, Sattler EC, Huang D, Teh BT, Motamedi M, Haas W, Iliopoulos O. Nat Commun. 2017;8:15866.

Cutaneous melanoma in Birt-Hogg-Dubé syndrome – part of the clinical spectrum?

Sattler EC,  Ertl-Wagner B,  Pellegrini C, Peris K, Reithmair M, Schädle N, Ruzicka T, Steinlein OK. Br J Dermatol, 2017. doi: 10.1111/bjd.15937.

Value of BIOCHIP technology in the serological diagnosis of pemphigoid gestationis.

Sadik CD, Pas HH, Bohlmann MK, Mousavi S, Benoit S, Sárdy M, Terra JB, Lima AL, Hammers CM, van Beek N, Bangert C, Zillikens D, Schmidt E. Acta Derm Venereol 2017; 96(7):128-130.

Proximal onycholysis as a complication of hand, foot and mouth disease.

Bagci IS, Flaig MJ, Ruzicka T, Sárdy M. Int J Dermatol 2017; 56(3):e61-e62.

Diagnostic value of linear fluorescence along the basement membrane of sweat gland ducts in bullous pemphigoid.

Bagci IS, Horváth ON, Schmidt E, Ruzicka T, Sárdy M. Acta Derm Venereol 2017; in press.

Increased sensitivity along with high specificity of indirect immunofluorescence detecting IgG subclasses for diagnosis of bullous pemphigoid.

Jankásková J, Horváth ON, Varga R, Arenberger P, Schmidt E, Ruzicka T, Sárdy M. Clin Exp Dermatol 2017; in press.

Pemphigus vulgaris persistently localized to the nose with local and systemic response to topical steroids.

Zhang C, Goldscheider I, Ruzicka T, Sárdy M. Acta Derm Venereol. 2017; 97(9):1136-7.

Bullous pemphigoid.

Bagci IS, Horváth ON, Ruzicka T, Sárdy M. Autoimmun Rev 2017; in press.

Focal dermal hypoplasia (Goltz-Gorlin Syndrome): The cause is not known.

Giehl KA (2016) Hautarzt 67(7):583-585

Non-invasive diagnosis of sweat gland dysplasia using optical coherence tomography and reflectance confocal microscopy in a family with anhidrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome).

Reinholz M, Gauglitz GG, Giehl K, Braun-Falco M, Schwaiger H, Schauber J, Ruzicka T, Berneburg M, von Braunmühl T (2016) J Eur Acad Dermatol Venereol 30(4):677-82.

Eight Novel Mutations Confirm the Role of AAGAB in Punctate Palmoplantar Keratoderma Type 1 (Buschke-Fischer-Brauer) and Show Broad Phenotypic Variability.

Giehl KA, Herzinger T, Wolff H, Sárdy M, von Braunmühl T, Dekeuleneer V, Sznajer Y, Tennstedt D, Boes P, Rapprich S, Wagner N, Betz RC, Braun-Falco M, Strom T, Ruzicka T, Eckstein GN (2015) Acta Derm Venereol. 2016 May;96(4):468-472

Complement fixation test: an update of an old method for the diagnosis of bullous pemphigoid.

Jankásková J, Horváth ON, Varga R, Ruzicka T, Sárdy M. Acta Derm Venereol 2016; 96(1):197-201.

Desmoglein 3-dependent signaling regulates keratinocyte migration and wound healing.

Rötzer V, Hartlieb E, Winkler J, Walter E, Schlipp A, Sárdy M, Spindler V, Waschke J. J Invest Dermatol 2016; 136(1):301-310.

Successful rituximab treatment of juvenile bullous pemphigoid with esophageal scarring due to epitope spreading.

Sárdy M, Borovaya A, Horváth ON, Folwaczny C, Schmitt W, Schmidt T, Hertl M, Ruzicka T. J Dtsch Dermatol Ges 2016; 14(6):618-21. [peer-reviewed scientific letter]

Vasoactive therapy in systemic sclerosis: real-life therapeutic practice in more than 3000 patients.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N. J Rheumatol 2016; 43(1):66-74.

The Predict Study: Low risk for digital ulcer development in systemic sclerosis patients with increasing disease duration and lack of topoisomerase-1 antibodies.

Hunzelmann N, Riemekasten G, Becker M, Moinzadeh P, Kreuter A, Melchers I, Mueller-Ladner U, Meier F, Worm M, Lee H, Herrgott I, Pfeiffer C, Fierlbeck G, Henes J, Juche A, Zeidler G, Mensing H, Günther C, Sárdy M, Burkhardt H, Koehm M, Kuhr K, Krieg T, Sunderkötter C. Br J Dermatol 2016; 174(6):1384-7.

Diagnostic performance of the "MESACUP anti-Skin profile TEST".

Horváth ON, Varga R, Kaneda M, Schmidt E, Ruzicka T, Sárdy M. Eur J Dermatol 2016; 26(1):56-63.

Entzündliche orale Schleimhauterkrankungen.  [Inflammatory diseases of oral mucous membranes].

Horváth ON, Kapser C, Sárdy M. Hautarzt 2016; 67(10):786-92.

Immunochip-based analysis: high-density genotyping of immune-related loci sheds further light on the autoimmune genetic architecture of alopecia areata.

Redler S, Angisch M, Heilmann S, Wolf S, Barth S, Basmanav BF, Giehl KA, Hanneken S, Eigelshoven S, Mangold E, Kruse R, Blaumeiser B, Böhm M, Knapp M, Garcia Bartels N, Lutz G, Wolff H, Blume-Peytavi U, Nöthen MM, Becker T, Betz RC (2015) J Invest Dermatol 135 (3): 919-921

Eight novel mutations confirm the role of AAGAB in punctate palmoplantar keratoderma type Buschke-Fischer-Brauer and show broad phenotypic variability. Acta Derm Venereol, im Druck

Giehl KA, Maier T, Herzinger T, Wolff H, Sardy M, Dekeuleneer V, Sznajer Y, Tennstedt D, Boes P, Ruzicka T, Rapprich S, Wagner N, Betz RC, Braun-Falco M, Strom T, Eckstein GN

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

Kapser C, Herzinger T, Ruzicka T, Flaig M, Molin S. J Eur Acad Dermatol Venereol. 2015;29(4):783-788.

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N; and all participating DNSS centers. Ann Rheum Dis 2015; 74(4):730-7.

Successful methotrexate treatment of oesophageal pemphigus vulgaris in an immunosuppressed patient with Crohn's disease.

Horváth ON, Borovaya A, Roider E, Klose J, Hartlieb E, Waschke J, Ruzicka T, Sárdy M. Acta Derm Venereol 2015; 95(7):868-869.

S2k Leitlinie zur Diagnostik des Pemphigus vulgaris / foliaceus und des bullösen Pemphigoids.

Schmidt E, Goebeler M, Hertl M, Sárdy M, Sitaru C, Eming R, Hofmann S, Hunzelmann N, Kern JS, Kramer H, Orzechowski HD, Pfeiffer C, Schuster V, Sporbeck B, Sticherling M, Worm M, Zillikens D, Nast A. [Article in German: S2k Guidelines for diagnosis of pemphigus vulgaris / foliaceus and bullous pemphigoid]. JDDG 2015; 13(7):713-27.

Childhood epidermolysis bullosa acquisita with underlying celiac disease.

Kasperkiewicz M, Orosz I, Abeck D, Koletzko S, Ruzicka T, Sárdy M. Acta Derm Venereol 2015; 95(8):1013-4.

Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population.

Hirose M, Schilf P, Benoit S, Eming R, Gläser R, Homey B, Kunz M, Nebel A, Peitsch WK, Pföhler C, Sárdy M, Schreiber S, Zillikens D, Schmidt E, Ibrahim SM; German AIBD Genetic Study Group. Exp Dermatol 2015; 24(9):715-7.

Allelic and copy-number variations of Fcg receptors affect the function of granulocytes and the susceptibility to autoimmune blistering diseases.

Recke A, Vidarsson G, Ludwig RJ, Freitag M, Möller S, Vonthein R, Schellenberger J, Haase O, Görg S, Nebel A, Flachsbart F, Schreiber S, Gläser R, Benoit S, Sárdy M, Eming R, Zillikens D, König IR, Schmidt E, Ibrahim S; German AIBD Genetic Study Group. J Autoimmun 2015; 61:36-44.

Pemphigoiderkrankungen – Autoimmunerkrankungen des Alters [Pemphigoid diseases: autoimmune diseases of the elderly].

Horváth ON, Jankásková J, Walker A, Sárdy M. Hautarzt 2015; 66(8):583-8.

Bullöses Pemphigoid. Auto-immunserologie und direkte Immunfluoreszenz sichern die Diagnose. [Bullous pemphigoid. Autoimmune serology and direct immunofluorescence ensure the diagnosis.]

Jankásková J, Horváth ON, Walker A, Sárdy M. hautnah dermatologie 2015; 31(6):24-27.

A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources.

Giehl KA, Kriz M, Grahovac M, Ruzicka T, Berking C (2014) Eur J Dermatol 24(3):335-41

Neonatal blue light phototherapy increases café-au-lait macules in preschool children.

Wintermeier K, von Poblotzki M, Genzel-Boroviczény O, Vogel S, Schotten K, Berking C, Giehl KA (2014) Eur J Pediatr 173 (11): 1519-1525

Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss.

Nuwaihyd R, Redler S, Heilmann S, Drichel D, Wolf S, Birch P, Dobson K, Lutz G, Giehl KA, Kruse R, Tazi-Ahnini R, Hanneken S, Böhm M, Miesel A, Fischer T, Wolff H, Becker T, Garcia-Bartels N, Blume-Peytavi U, Nöthen MM, Messenger AG, Betz RC (2014) Arch Dermatol Res 306 (4): 413-418

The oestrogen receptor 2 (ESR2) gene in female-pattern hair loss: replication of association with rs10137185 in German patients.

Redler S, Birch P, Drichel D, Hofmann P, Dobson K, Böhmer AC, Becker J, Giehl KA, Tazi-Ahnini R, Kruse R, Wolff H, Miesel A, Fischer T, Böhm M, Nuwayhid R, Garcia Bartels N, Lutz G, Becker T, Blume-Peytavi U, Nöthen MM, Messenger AG, Betz RC (2014) Br J Dermatol 170 (4):982-985.

Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.

Ruëff F, Vos B, Oude Elberink J, Bender A, Chatelain R, Dugas-Breit S, Horny HP, Küchenhoff H, Linhardt A, Mastnik S, Sotlar K, Stretz E, Vollrath R, Przybilla B, Flaig M. Clin Exp Allergy. 2014; 44:736-46.

Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.

Berezowska S, Flaig MJ, Ruëff F, Walz C, Haferlach T, Krokowski M, Kerler R, Petat-Dutter K, Horny HP, Sotlar K. Mod Pathol. 2014; 27:19-29.

Childhood lichen planus pemphigoides: report of two cases treated successfully with systemic glucocorticoids and dapsone.

Goldscheider I, Herzinger T, Varga R, Eming R, Ruzicka T, Flaig MJ, Sárdy M. Pediatr Dermatol 2014; 31(6):751-3.

Longitudinal leukonychia striata: is it a common sign in Hailey-Hailey and Darier disease?

Kostaki D, Castillo JC, Ruzicka T, Sárdy M. J Eur Acad Dermatol Venereol 2014; 28:126-7. [peer-reviewed scientific letter]

Successful therapy of refractory Hailey-Hailey disease with oral alitretinoin.

Sárdy M, Ruzicka T. Br J Dermatol 2014; 170(1):209-11. [peer-reviewed scientific letter]

Bullöse Autoimmunkrankheiten bei Kindern. [Bullous autoimmune disorders in children.]

Sárdy M, Kasperkiewicz M. Monatsschr Kinderheilkd 2014; 162:259-68.

Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss.

Redler S, Dobson K, Drichel D, Heilmann S, Wolf S, Brockschmidt FF, Tazi-Ahnini R, Birch P, Teßmann P, Giehl KA, Kruse R, Lutz G, Garcia Bartels N, Hanneken S, Wolff H, Böhm M, Becker T, Blume-Peytavi U, Nöthen MM, Messenger AG, Betz RC (2013) J Dermatol Sci 72 (2): 186-188

Pili annulati: a report of 2 American families.

Berk DR, Bayliss SJ, Giehl KA (2013) Cutis 91 (5): 254-257

Selected variants of the melanocortin 4 receptor gene (MC4R) do not confer susceptibility to female pattern hair loss.

Mahmoudi H, Redler S, Birch P, Drichel D, Dobson K, Tazi-Ahnini R, Teßmann P, Giehl KA, Kruse R, Lutz G, Hanneken S, Wolff H, Blume-Peytavi U, Becker T, Nöthen MM, Messenger AG, Böhm M, Betz RC (2013) Arch Dermatol Res 305 (3): 249-253

Sentinel lymph node in merkel cell carcinoma: to biopsy or not to biopsy?

Sattler E, Geimer T, Sick I, Flaig MJ, Ruzicka T, Berking C*, Kunte C* (2013) J Dermatol 40:374-379 *Autoren teilen Seniorautorschaft (IF 1,5)

Molecular diagnostics in cutaneous lymphomas.

Möbs M, Cerroni L, Flaig MJ, Lenze D, Hummel M, Assaf C. J Dtsch Dermatol Ges. 2013;11 Suppl 4:25-35.

Bullöse Autoimmunkrankheiten bei Kindern. [Bullous autoimmune disorders in children.]

Sárdy M, Kasperkiewicz M. Hautarzt 2013; 64(6):447-57.

Selected variants of the steroid-5-alpha-reductase isoforms SRD5A1 and SRD5A2 and the sex steroid hormone receptors ESR1, ESR2 and PGR: no association with female pattern hair loss identified.

Redler S, Tazi-Ahnini R, Drichel D, Birch MP, Brockschmidt FF, Dobson K, Giehl KA, Refke M, Kluck N, Kruse R, Lutz G, Wolff H, Böhm M, Becker T, Nöthen MM, Betz RC, Messenger A. (2012) Exp Dermatol 21 (5): 390-393.

Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss.

Redler S, Brockschmidt FF, Tazi-Ahnini R, Drichel D, Birch MP, Dobson K, Giehl KA, Herms S, Refke M, Kluck N, Kruse R, Lutz G, Wolff H, Böhm M, Becker T, Nöthen MM, Messenger AG, Betz RC (2012) Brit J Dermatol 166 (6): 1314-1318.

Nonsense mutations in AAGAB cause punctate palmoplantar keratoderma type Buschke-Fischer-Brauer.

Giehl KA, Eckstein GN, Pasternack SM, Praetzel-Wunder S, Ruzicka T, Lichtner P, Seidl K, Rogers M, Graf E, Langbein L, Braun-Falco M, Betz RC, Strom TM (2012) Am J Hum Genet 91 (4): 754-759

Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata.

Redler S, Albert F, Brockschmidt FF, Herold C, Hanneken S, Eigelshoven S, Giehl KA, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC (2012) Br J Dermatol 167 (6): 1360-1365

Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance.

Jagielska D, Redler S, Brockschmidt FF, Herold C, Pasternack SM, Garcia Bartels N, Hanneken S, Eigelshoven S, Refke M, Barth S, Giehl KA, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Blume-Peytavi U, Becker T, Nöthen MM, Betz RC (2012) J Invest Dermatol 132 (9): 2192-2197

Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata.

Forstbauer LM, Brockschmidt FF, Moskvina V, Herold C, Redler S, Herzog A, Hillmer AM, Meesters C, Heilmann S, Albert F, Alblas M, Hanneken S, Eigelshoven S, Giehl KA, Jagielska D, Blume-Peytavi U, Garcia Bartels N, Kuhn J, Hennies HC, Goebeler M, Jung A, Peitsch WK, Kortüm AK, Moll I, Kruse R, Lutz G, Wolff H, Blaumeiser B, Böhm M, Kirov G, Becker T, Nöthen MM, Betz RC (2012) Eur J Hum Genet 20 (3): 326-332

Loss-of-function mutations in HOXC13 cause pure hair and nail ectodermal dysplasia. Am J Hum Genet 91 (5): 906-911

Lin Z, Chen Q, Shi L, Lee M, Giehl KA, Tang Z, Wang H, Zhang J, Yin J, Wu L, Xiao R, Liu X, Dai L, Zhu X, Li R, Betz RC, Zhang X, Yang Y (2012)

Late onset of skin manifestations in Birt-Hogg-Dubé syndrome with FLCN mutation p.W260X.

Sattler EC*, Lang M*, van Steensel MAM, van Geel M, Schneider J, Flaig MJ, Ruzicka T, Burgdorf W, Steinlein OK. Acta Derm Venerol 2012; 92:187-188.

Steatocystoma multiplex: keratin 17 - the key player?

Antal AS, Kulichova D, Redler S, Betz RC, Ruzicka T. (2012) Br J Dermatol 2012;167:1395-1397.

Concomitant manifestation of pili annulati and alopecia areata: coincidental rather than a true association? Acta Derm Venereol 91: 459-462

Giehl KA, Eckstein GN, Pasternack SM, Praetzel-Wunder S, Ruzicka T, Lichtner P, Seidl K, Rogers M, Graf E, Langbein L, Braun-Falco M, Betz RC, Strom (2011)

rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from  Netherton patients. J Dermatol Sci 61 (3): 194-198

Roedl D, Oji, Buters JT, Behrendt H, Braun-Falc o M (2011)

Genital ulcers associated with Epstein-Barr virus infection (ulcus vulvae acutum). Acta Derm Venereol. 2011; 91(1):55-9.

Sárdy M, Wollenberg A, Niedermeier A, Flaig MJ.

Spiny acral hyperkeratosis in coincidence with malignant melanoma. Clin Exp Dermatol. 2011; 36(3):307-9.

Friedl TK, Sárdy M, Herzinger T, Ruzicka T, Braun- Falco M.

Bosentan is effective in the management of both digital ulcerations and hyperkeratosis in system ic sclerosis. Acta Derm Venereol 2011; in press.

Kurgyis Zs, Varga R, Sick I, Lang MU, Ruzicka T, Sárdy M.

Effects of topical treatment with the raft modulator miltefosine and clobetasolin cutaeous mastocytosis: a randomized, double-bli

Hartmann K, Siebenhaar F, Belloni B, Brockow K, Eben R, Hartmann B, Rueff F, Schoepke N, Staubach P, Weber A, Maurer M (2010)

Genetisch bedingte Pigmentstörungen, Hautarzt 61 (7) 567-577

Giehl KA, Braun-Falco M (2010)

Prevalence of Merkel cell  polyomavirus DNA in cutaneous lymphomas, pseudolymphomas, and inflammatory skin diseases.

Andres C, Puchta U, Sander CA, Ruzicka T, Flaig MJ.  Am J Dermatopathol. 2010;32(6):593-598.

Topical glucocorticoids and calcineurin inhibitors in cutaneous lupus erythematosus.

Sárdy M, Ruzicka T, Kuhn A. J Clin Dermatol 2010, in press.

Hair interior defect (hid) in AKR/J mice. Clin Exp Dermatol, 34: 509-517

Giehl KA, Potter CS, Wu B, Silva KA, Rowe L, Awgulewitsch A,  Sundberg JP (2009)

Dermatitis herpetiformis. An update of the pathogenesis. Hautarzt 60 (8): 627-630

Sárdy M, Tietze J (2009)

Stinging Hymenoptera and mastocytosis. Curr Opin Allergy Clin Immunol 9 (4): 338-342

Rueff F, Dugas-Breit S, Przybilla B (2009)

Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyod erma gangrenosum and acne) syndrome with the recombiant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 1

Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P (2009)

Topical calcineurin inhibitors in cutaneous lupus erythematosus. Arch Dermatol Res. 2009 Jan;301(1):93-8.

Sárdy M, Ruzicka T, Kuhn A.

Pili annulati- Refined mapping to a 2.9 Mb interval on chromosome 12q24.33 and investigation of candidate genes and sequencing of candidate genes. Br J Dermatol, 160: 527-533.

Giehl KA, Rogers M, Radivojkov M, Tosti A, de Berker DAR, Schmuth M, Ruzicka T, Eckstein G (2008)

Resoration of fatty al dehyde dehydrogenase deficiency in Sjögren-Larsson Syndrome. Gene Ther 13:1021-1026

Haug S, Braun-Falco M (2006)

Cytokeratin expression in pili annulati hair follicles. Clin Exp Dermatol 30: 426-428

Giehl KA, Dean D, Dawber RPR, Leigh I, de Berker DAR, Wojnarowska F (2005)

Update on detection, morphology and fragility in pili annulati in 3 kindreds. J Eur Acad Dermatol Venereol 18: 654-658.

Giehl KA, Ferguson DJP, Dawber RPR, Pittelkow MR, Foehles J, de Berker DAR (2004)

Alterations in the basement membrane zone in pili annulati hair follicles as demonstrated by electron microscopy and immunohistochemistry. Br J Dermatol 150: 722-727

Giehl KA, Ferguson DJP, Dean D, Chuang YH, Allen J, de Berker DAR, Tosti A, Dawber RPR, Wojnarowska F (2004)

A gene locus responsible for the familial hair shaft abnormality pili annulati maps to chromosome 12q24.32-24.33. J Invest Dermatol 123: 1073-1077

Giehl KA, Eckstein GN, Benet-Pages A, Tosti A, de Berker DAR, Meitinger T, Müller-Myhsok B, Strom TM (2004)